Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
30.19
-0.29 (-0.95%)
At close: Aug 14, 2025, 3:59 PM
30.21
0.07%
Pre-market: Aug 15, 2025, 08:45 AM EDT
-0.95%
Bid 28.82
Market Cap 1.4B
Revenue (ttm) 728.26M
Net Income (ttm) 141.63M
EPS (ttm) 2.67
PE Ratio (ttm) 11.31
Forward PE 6.76
Analyst Hold
Ask 30.25
Volume 386,620
Avg. Volume (20D) 542,938
Open 30.03
Previous Close 30.48
Day's Range 29.64 - 30.63
52-Week Range 20.39 - 53.96
Beta 0.76

About AMPH

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMPH
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AMPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Amphastar Pharmaceuticals has released their quartely earnings on Aug 7, 2025:
  • Revenue of $174.41M misses estimates by $9.08M, with -4.38% YoY decline.
  • EPS of 0.85 exceeds estimates by 0.15, with -9.57% YoY decline.
  • Next Earnings Release

    Amphastar Pharmaceuticals Inc. is scheduled to release its earnings on Nov 5, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 days ago
    +10.93%
    Amphastar Pharma shares are trading higher after N... Unlock content with Pro Subscription
    3 days ago
    +14.91%
    Amphastar Pharmaceuticals shares are trading higher after the company announced FDA approval for its iron sucrose injection.